You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM™) adoptive cell therapy (ACT) T cells

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM™) adoptive cell therapy (ACT) T cells

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023176013
Dec 20235705
Jan 20242601
Feb 20242201
Mar 20242801
Apr 20241800
May 20243401
Jun 20241602
Jul 2024600
Aug 20241801
Sep 20242801
Oct 202452011
Nov 20243006
Dec 20242603
Jan 20251806
Feb 2025803
Mar 2025102
Apr 2025002
May 2025002
Jun 2025003
Total564064